Literature DB >> 4043145

Absorption, tissue distribution, and excretion of 3H-labeled arbaprostil in the male rat.

A J Sinha, S R Shaw, B A Thornburgh.   

Abstract

A single dose of arbaprostil-11 beta-3H (4 micrograms/kg) was administered orally to male rats. A maximum plasma radioactivity concentration equivalent to 2.5 to 2.8 nanograms of the prostaglandin per ml was reached at 30 minutes and was maintained until 120 minutes after drug administration. The plasma drug disappearance half-life was 2.6 hours. These results along with data from tissue distribution studies suggested a rapid uptake of radiolabeled arbaprostil by the glandular stomach tissue followed by an apparent zero-order release of drug-related radioactivity from this tissue "reservoir" into the plasma. Drug-related radioactivity was excreted rapidly, with 96 to 99% of the urinary excretion and 82 to 97% of the fecal excretion being completed within 24 hours. A total of 49.6 +/- 3.5% of the orally administered dose was excreted in the urine and 46.7 +/- 3.9% in the feces. No radioactive residues were detected in the animals at the end of the 120 hour specimen collection period. The metabolic stability of the 11 beta-tritium label and the suitability of arbaprostil-3H for use in human studies was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043145     DOI: 10.1007/BF03189712

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  13 in total

1.  THE BIOLOGICAL HALF-LIFE OF TRITIATED WATER IN THE MOUSE, RAT, GUINEA-PIG AND RABBIT UNDER TROPICAL CONDITIONS AND THE EFFECT OF CLIMATE AND SALINE DRINKING ON THE BIOLOGICAL HALF-LIFE OF TRITIATED WATER IN THE RAT.

Authors:  J M FOY
Journal:  J Cell Comp Physiol       Date:  1964-10

2.  PROSTAGLANDINS AND RELATED FACTORS. 27. SYNTHESIS OF TRITIUM-LABELED PROSTAGLANDIN E1 AND STUDIES ON ITS DISTRIBUTION AND EXCRETION IN THE RAT.

Authors:  B SAMUELSSON
Journal:  J Biol Chem       Date:  1964-12       Impact factor: 5.157

3.  The distribution of tritium-labelled prostaglandin E(1) injected in amounts sufficient to produce central nervous effects in cats and chicks.

Authors:  S W Holmes; E W Horton
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

4.  The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients.

Authors:  W Peterson; M Feldman; I Taylor; M Bremer
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

5.  An autoradiographic study of prostaglandin E1 and-or its metabolites in mouse kidney tissue.

Authors:  R Landolt; S M Shaw; R J Vetter; S H Chen
Journal:  Prostaglandins       Date:  1974-02-10

6.  Tissue distribution and subcellular localization of H3-prostaglandin E1 in rats and dogs.

Authors:  J Nakano
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-09

Review 7.  Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.

Authors:  A Robert; J R Schultz; J E Nezamis; C Lancaster
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man.

Authors:  S J Konturek; N Kwiecień; J Swierczek; J Oleksy; E Sito; A Robert
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

9.  Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.

Authors:  A Robert; G Kane; S B Reele
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

10.  Gastrointestinal protection by low-dose oral prostaglandin E2 in rheumatic diseases.

Authors:  B Kollberg; R Nordemar; C Johansson
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

View more
  1 in total

1.  Isolation and characterization of the urinary metabolites of arbaprostil in the male dog after intravenous administration.

Authors:  B A Thornburgh; S R Shaw; G E Bronson; A J Sinha
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Apr-Jun       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.